Healthcare >> CEO Interviews >> February 19, 2001
SHALOM Z. HIRSCHMAN, MD is President and CEO of Advanced Viral Research
Corporation. After a 28-year affiliation with The Mount Sinai School of
Medicine and The Mount Sinai Hospital, Dr. Hirschman joined Advanced
Viral Research Corp. as President and CEO at the end of 1996. Earlier
this year, Dr. Hirschman established the Advanced Viral Research
Institute, a wholly owned subsidiary, to enable senior scientists to
pursue basic biomedical research in an academically'oriented
environment. Dr. Hirschman has been published in many peer-reviewed
journals, including The New England Journal of Medicine, Nature and
Science. He founded one of New York City's first and most active AIDS
treatment centers at Mount. Sinai. Dr. Hirschman is a graduate of the
Albert Einstein College of Medicine. He was both an Intern and a
Resident at the Massachusetts General Hospital, Harvard Medical School.
He then spent seven years doing basic molecular research at the National
Institutes of Health in Bethesda, Maryland. Dr. Hirschman is a Fellow of
the American Society of Infectious Diseases, a member of the American
Society for Clinical Investigation, the American Association of
Physicians, the American College of Clinical Pharmacology, the Royal
College of Hygiene and Tropical Medicine, the American Biophysical
Society, the American Society of Microbiology, and the Society of
General Virology, among others. Profile
Viral Research Corp.?
Dr. Hirschman: Advanced Viral Research Corp. is a biopharmaceutical
company that is developing a
